Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2012 / Cilt: 22 - Sayı: 2

Giant adrenocortıcal carcınoma

Dev adrenokortikal karsinom

Pages
125–128
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Histopathological diagnosis of the resected specimen was reported as adrenocortical carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report a 57- year-old male admitted with abdominal pain and swelling.
📊
Key Findings & Data:The abdominal computerized tomography showed a large mass 20 cm in diameter which filled the left hypocondrium.
💡
Conclusion & Impact:Histopathological diagnosis of the resected specimen was reported as adrenocortical carcinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We report a 57- year-old male admitted with abdominal pain and swelling. The abdominal computerized tomography showed a large mass 20 cm in diameter which filled the left hypocondrium. Histopathological diagnosis of the resected specimen was reported as adrenocortical carcinoma.

Özet

Karında şişlik ve ağrı ile başvuran 56 yaşındaki erkek hastanın abdominal bilgisayarlı tomografisinde sol hipokondriyumu tama yakın dolduran 20 cm çaplı bir kitle saptandı.Tümörün tam cerrahi rezeksiyonu sağlandı ve histopatolojik tanı adrenokortikal karsinom olarak sonuçlandı.

🔖

Cite This Article

KEBAPÇI, E., DOĞAN, S. M., KARAMAN, K., CUMURCU, S., BAYOL, Ü., TUĞMEN, C., ÖLMEZ, M., KARACA, C., ÖZTÜRK, Ş., ÜNLÜOĞLU, S. (2012). Giant adrenocortıcal carcınoma. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 22 - Sayı: 2, 125–128. https://ajindex.com/articles/268410

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Norton JA. Adrenal tumors. In De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005; 1528-39
  2. Luton JP, Cerdas S, Billaud L. et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990; 322 (17): 1195-201
  3. Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses.Semin Urol Oncol. 1995; 13 (4):254-61
  4. Singh O, Gupta SS. Giant adrenal cortical carcinoma. Saudi J Kidney Dis Transpl 2011; 22: 153-5
  5. Becherer A, Vierhapper H, Pötzi C. et al. FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 2001; 16 (4): 289-95
  6. Young Jr WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007; 356 (6): 601–10
  7. Zini L, Porpiglia F, Fassnacht M. Contemporary management of adrenocortical carcinoma. Eur Urol 2011; 60 (5): 1055-65
  8. Allolio B, Fassnacht M. Clinical review. Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006; 91 (6): 2027-37
  9. Icard P, Goudet P, Charpenay C. et al Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 2001; 25 (7): 891-7
  10. Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999; 6 (8): 719-26
  11. Icard P, Louvel A, Chapuis Y. Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 1992; 16 (4): 753-8
  12. Gaujoux S, Brennan MF. Recommendation for standardized surgical management of primary adrenocortical carcinoma. Surgery 2012; 152 (1): 123-32
  13. Berruti A, Fassnacht M, Baudin E. et al. Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. J Clin Oncol. 2010; 28 (23): 401-2
  14. De Vita VT, Hellman S, Rosenberg SA. Cancer: Principles and practice of oncology. Philadelphia: Lippincott-Raven 2005; ISBN 0-7817-4865-8.